J. Longmore - Concepedia

Author

J. Longmore

MSD (UK) Limited (United Kingdom)

Also Known As

J Longmore, J M Longmore, J. LONGMORE, J. Longmore, J. M. Longmore, Jeanette Longmore, Longmore, James, S Pillai

Publications

Citations

H-Index

106

Concepts

All Affiliations

MSD (UK) Limited (United Kingdom)Merck & Co., Inc., Rahway, NJ, USA (United States)University of Manchester Addenbrooke's Hospital Merck (United Kingdom)

About

J. Longmore is an author at MSD (UK) Limited (United Kingdom) specializing in medicine, pharmacology, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	22	853
2	Engineering	5	5	362
3	Health Sciences	4	4	213
4	Natural Sciences	2	2	44
5	Education	1	1	25

J. Longmore

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Glare from windows: current views of the problem Patrick Chauvel, J.B. Collins, R. Dogniaux, Lighting Research & Technology Illumination ModelingArtificial Light SourcesEngineeringOphthalmologyOptic Design	1982	236
Differential Distribution of 5Ht<sub>1D</sub>-and 5HT<sub>1B</sub>-Immunoreactivity within the Human Trigemino-Cerebrovascular System: Implications for the Discovery of New Antimigraine Drugs J. Longmore, David E. Shaw, David W. Smith, Cephalalgia	1997	223
Psychological stress and the passage of a standard meal through the stomach and small intestine in man P A Cann, N W Read, Jocelyn Cammack, Gut NutritionGastroenterologyHealth PsychologyMental HealthPsychology	1983	127
Antinociceptive activity of NK<sub>1</sub> receptor antagonists: non‐specific effects of racemic RP67580 N.M.J. Rupniak, S. Boyce, Angela Williams, British Journal of Pharmacology Pain DisordersPain MedicineSynaptic TransmissionImmunologyNeuropathic Pain	1993	93
The action of diazoxide and minoxidil sulphate on rat blood vessels: a comparison with cromakalim Donald Newgreen, K.M. Bray, Aileen McHarg, British Journal of Pharmacology	1990	86
Differences between the effects of cromakalim and nifedipine on agonist‐induced responses in rabbit aorta K.M. Bray, A.H. Weston, Susan Duty, British Journal of Pharmacology	1991	69
Pharmacological specificity of novel, synthetic, cyclic peptides as antagonists at tachykinin receptors A.T. McKnight, Janet J. Maguire, N.J. Elliott, British Journal of Pharmacology ImmunologyTachykinin ReceptorsCellular PharmacologyPharmacotherapyExperimental Pharmacology	1991	62
An Immunocytochemical Investigation of Human Trigeminal Nucleus Caudalis: Cgrp, Substance P and 5-Ht<sub>1D</sub>-Receptor Immunoreactivities Are Expressed by Trigeminal Sensory Fibres David W. Smith, R M Hill, Lars Edvinsson, Cephalalgia Health SciencesNeuroanatomyImmunocytochemical InvestigationPhysiologyImmunology	2002	62
Neurokinin-receptor antagonists: pharmacological tools and therapeutic drugs J. Longmore, R.G. Hill, Richard Hargreaves Canadian Journal of Physiology and Pharmacology Neurokinin-receptor AntagonistsMedicineNeuropeptide ReceptorPharmacological AgentNeuropharmacology	1997	61
Effects of two truncated forms of human calcitonin-gene related peptide: implications for receptor classification J. Longmore, Joanne E. Hogg, Peter H. Hutson, European Journal of Pharmacology NeuropeptidesSignal TransductionMedicinePhysiologyReceptor (Biochemistry)	1994	49

Page 1